SCHEMBL2286583

SCHEMBL2286583

Brc1ccc2cc(Br)c3ccccc3c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.51
CYP2D6 P10635 2/20 0.51
CYP2A6 P11509 2/20 0.50
ALDH1A1 P00352 8/20 0.49
CYP1A2 P05177 5/20 0.49
CYP2C9 P11712 2/20 0.49
HSD17B10 Q99714 4/20 0.46
HIF1A Q16665 1/20 0.46
CYP1B1 Q16678 1/20 0.46
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
RXFP1 Q9HBX9 1/20 0.44
HPRT1 P00492 1/20 0.39
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
TRPM4 Q8TD43 1/20 0.37
HTT P42858 2/20 0.36
HPGD P15428 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
PRNP P04156 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27889341 0.87 MEN1 (0.59) CYP2C19CYP2D6CYP2A6ALDH1A1CYP1A2
SCHEMBL11181615 0.86 ALDH1A1 (0.43) CYP2C19CYP2D6CYP2A6ALDH1A1CYP1A2
SCHEMBL22165497 0.84 CYP2A6 (0.48) CYP2C19CYP2D6CYP2A6ALDH1A1CYP1A2
SCHEMBL28165045 0.84 MEN1 (0.46) CYP2C19CYP2D6CYP2A6ALDH1A1CYP1A2
SCHEMBL31340097 0.84 MEN1 (0.46) CYP2C19CYP2D6CYP2A6ALDH1A1CYP1A2
SCHEMBL184768 0.83 ALDH1A1 (0.59) CYP2C19CYP2D6CYP2A6ALDH1A1CYP1A2
SCHEMBL14973721 0.83 CYP2A6 (0.41) CYP2C19CYP2D6CYP2A6ALDH1A1CYP1A2
SCHEMBL30148754 0.83 CYP2A6 (0.41) CYP2C19CYP2D6CYP2A6ALDH1A1CYP1A2
SCHEMBL723041 0.82 HPRT1 (0.64) CYP2C19CYP2A6ALDH1A1CYP1A2CYP2C9
SCHEMBL2300244 0.81 ALDH1A1 (0.56) CYP2C19CYP2D6CYP2A6ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10608189-B2 Condensed cyclic compounds and organic light-emitting devices including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-31 US disclosed
US-20190013483-A1 CONDENSED CYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-01-10 US disclosed
US-10069083-B2 Condensed cyclic compounds and organic light-emitting devices including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-09-04 US disclosed
US-20150349275-A1 CONDENSED CYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-03 US disclosed
US-20150349275-A1 CONDENSED CYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-03 US disclosed
US-20150349275-A1 CONDENSED CYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-03 US disclosed
US-20140175383-A1 INDENOTRIPHENYLENE DERIVATIVES AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2014-06-26 US disclosed
US-20140175383-A1 INDENOTRIPHENYLENE DERIVATIVES AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2014-06-26 US disclosed
US-20140131664-A1 INDENOTRIPHENYLENE DERIVATIVES AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2014-05-15 US disclosed
US-20140131664-A1 INDENOTRIPHENYLENE DERIVATIVES AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2014-05-15 US disclosed
US-20110186831-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10608189-B2 Condensed cyclic compounds and organic light-emitting devices including the same CRY1, CRY2, CCNE2 CYP2C19 480/4885CYP2D6 2204/4885CYP2A6 2170/4885
US-20190013483-A1 CONDENSED CYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP2C19 480/4885CYP2D6 2204/4885CYP2A6 2170/4885
US-20110186831-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME CTCF, SOX18, HNRNPH3 CYP2C19 912/4885CYP2D6 2015/4885CYP2A6 2820/4885
US-20140131664-A1 INDENOTRIPHENYLENE DERIVATIVES AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME AHR, AIPL1, CYP1A1 CYP2C19 72/4885CYP2D6 159/4885CYP2A6 69/4885
US-10069083-B2 Condensed cyclic compounds and organic light-emitting devices including the same CRY1, CRY2, CCNE2 CYP2C19 480/4885CYP2D6 2204/4885CYP2A6 2170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.